Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.

  • Presentation

Keys to Successful Dermatopathology Practice: Quality, Leadership, Advocacy, and Business Strategy

Description

The speaker offers practical advice for building a successful dermatopathology practice, emphasizing that clinicians should intentionally set aside time to evaluate their practice using tools like SWOT analysis and Porter’s Five Forces. Key themes include understanding competitors, supply and staffing challenges, reimbursement pressures, regulatory issues, and future threats such as AI or alternative diagnostic technologies. The talk stresses advocacy because dermatopathology reimbursement has remained stagnant or declined over time, making engagement in policy and billing issues essential. The speaker also highlights the importance of having a clear mission focused on patient care, maintaining high quality through training, root-cause analysis, and continuous improvement, and treating mistakes as opportunities to get better. Strong service, communication, and convenient billing and logistics for referring physicians are presented as critical for retaining contributors and delivering timely, accurate results. Leadership and management skills are described as learned rather than innate, and the speaker encourages building a supportive team culture, working hard, staying open to new ideas, continuously learning, and participating in advocacy to improve the field.

View more

Conclusions

  • Successful dermatopathology practice requires deliberately making time to review, analyze, and improve the practice rather than relying on day-to-day busyness.
  • Practices should use business tools such as SWOT and Porter’s Five Forces to understand competition, supplier constraints, substitution threats, and market entry pressures.
  • Limited staffing, especially a shortage of histotechnologists, and changing technology make workforce and equipment planning essential.
  • Dermatopathologists need to stay engaged with AI and other emerging diagnostic technologies so they influence development rather than react to it later.
  • Regulation and especially reimbursement are major external forces, and stagnant payment for common pathology codes makes advocacy necessary.
  • A clear shared mission focused on the best patient diagnosis and care helps align the entire team.
  • Quality improves when teams are well trained, processes are understood, and near misses are treated as opportunities for root-cause analysis and prevention.
  • Tools such as the five whys, fishbone diagrams, and repeated Plan-Do-Study-Act cycles can uncover underlying problems and drive improvement.
  • Making the service easy for contributors through simple billing, convenient couriers, timely reports, and responsive communication is critical for retaining cases.
  • Turnaround time must be balanced with diagnostic quality rather than treated as the only goal.
  • Running a successful practice requires basic management and leadership skills such as accounting, finance, hiring, compliance, and people management.
  • Strong relationships, excellent communication, and a diversified contributor base are central to sustaining a dermatopathology practice.
  • A successful practice is defined not by money alone but by providing the best diagnosis for patients and maintaining a team that enjoys learning and working together.
  • Culture matters: camaraderie, teamwork, caring, curiosity, hard work, and setting an example all support practice success.
  • The field must keep learning, adapt to digital pathology and molecular advances, and give back through teaching, volunteering, and advocacy.
  • Heher YK. A brief guide to root cause analysis. Cancer Cytopathol. 2017 Feb;125(2):79-82. doi: 10.1002/cncy.21819. Epub 2017 Jan 27. PMID: 28128529.#10.1002/cncy.21819
  • Privalle AN, et al. Bundled intervention to improve patient safety by reducing skin specimen-related errors in a tertiary dermatology practice. J Am Acad Dermatol. 2021 Apr;84(4):1146-1148.#10.1016/j.jaad.2020.06.1020